Anti-MGAT5 antibody [3E9]
4
(5 리뷰들)
|
(8 제품이 사용된 논문 )
- Flow Cyt
Unknown
Flow Cytometry - Anti-MGAT5 antibody [3E9] (AB87977)
Overlay histogram showing Jurkat cells stained with ab87977 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab87977, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-mouse IgG (H&L) (ab150113) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in Jurkat cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
This image was generated using the ascites version of the product.
- WB
AbReview51060****
Western blot - Anti-MGAT5 antibody [3E9] (AB87977)
Blocking was via 5% milk in PBST incubated for 1 hour at 22°C
This image was generated using the ascites version of the product.
All lanes:
Western blot - Anti-MGAT5 antibody [3E9] (ab87977) at 1/2000 dilution
All lanes:
Human RWPE prostate cells at 20 µg
Secondary
All lanes:
Donkey anti-mouse polyclonal HRP conjugate at 1/10000 dilution
Predicted band size: 85 kDa
Observed band size: 55 kDa,95 kDa
true
Exposure time: 40s
Image is courtesy of an AbReview submitted by Armen Petrosyan.
Reactivity 정보
제품 세부 정보
특성 및 보관 정보
제형
Purity
Purification 관련 사항
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MGAT5 contributes to cellular processes such as cell-cell communication cell migration and signal transduction. These processes are important in tissues where it is expressed. MGAT5 is not part of a complex but works closely with other glycosyltransferases in the glycosylation pathway. Its glycan products interact with lectins and receptors on the cell surface influencing signaling pathways and cellular behavior.
Pathways
MGAT5 is significant in the glycosylation pathway and the PI3K/AKT signaling pathway. In these pathways MGAT5 modifies glycoproteins which can impact receptor function and downstream signaling. It interacts with proteins such as integrins and growth factor receptors affecting cellular responses to environmental cues and influencing growth and differentiation signals.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (8)
Recent publications for all applications. Explore the 전체 목록and refine your search
Journal of translational internal medicine 13:281-294 PubMed40896287
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nutrition & metabolism 21:53 PubMed39080739
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 13:1133476 PubMed37256183
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 124:797-807 PubMed37062903
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 237:1780-1789 PubMed34806177
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:128 PubMed33376510
2020
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 9:585-596 PubMed30949412
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:71867-71880 PubMed29069753
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com